Efficacy and safety of dabigatran versus warfarin from the RE-LY trial
Crossref DOI link: https://doi.org/10.1136/openhrt-2018-000800
Published Online: 2018-06-27
Published Print: 2018-06
Update policy: https://doi.org/10.1136/crossmarkpolicy
Avezum, Alvaro
Oliveira, Gustavo Bernardes de Figueiredo
Diaz, Rafael
Hermosillo, Jesus Antonio Gonzalez
Oldgren, Jonas
Ripoll, Ernesto Ferreiros
Noack, Herbert
Piegas, Leopoldo Soares
Connolly, Stuart J